![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
,2
* Western Human Nutrition Research Center, Agriculture Research Service, U.S. Department of Agriculture;
Department of Food and Nutrition, Seoul National University, Seoul, South Korea;
** Department of Medical Pathology, University of California Davis Medical Center;
The School of Public Health, Seoul National University, Seoul, South Korea;
Division of Nutritional Genomics, Children’s Hospital Oakland Research Institute, Oakland, CA; and
Department of Nutrition and Rowe Program in Genetics, University of California at Davis, Davis, CA 95616
2To whom correspondence should be addressed. E-mail: lhuang{at}whnrc.usda.gov.
A bioassay for zinc status in humans has been sought due to the importance of zinc, an essential trace metal, for many divergent functions in the human body; however, a sensitive bioassay for zinc status in humans is lacking. To address this issue, we established gene expression profiles of human lymphoblastoid cells treated with 0 or 30 µmol/L ZnSO4 using microarray technology. A limited number of genes were responsive to 30 µmol/L zinc based on the analysis of Affymetrix human genome U133A GeneChips. We also examined the gene expression patterns of zinc transporters in human lymphoblastoid cells using quantitative RT-PCR analysis. ZNT1 was upregulated in lymphoblastoid cells, whereas ZIP1 was downregulated in response to the increased zinc concentrations in the culture media. To evaluate the potential applications of using both zinc transporter genes as biomarkers of zinc status, we measured the expression levels of ZIP1 and ZNT1 in the peripheral leukocytes collected from 2 different age groups of Korean women. After administration of a zinc supplement (22 mg zinc gluconate/d for 27 d), ZIP1 expression decreased by 17% (P < 0.01) and 21% (P < 0.05) in the peripheral leukocytes collected from 15 young (20–25 y) and 10 elderly (64–75 y) subjects, respectively. ZNT1 expression was not affected by taking the zinc supplement. These data suggest a potential application of ZIP1 as a biomarker of zinc status in humans.
KEY WORDS: • zinc transporter • zinc supplementation • quantitative RT-PCR • microarray • humans
This article has been cited by other articles:
|
|
 |
|
  J. R Hunt, J. M Beiseigel, and L. K Johnson Adaptation in human zinc absorption as influenced by dietary zinc and bioavailability Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1336 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Overbeck, P. Uciechowski, M. L. Ackland, D. Ford, and L. Rink Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9 J. Leukoc. Biol., February 1, 2008; 83(2): 368 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Huang, Y. Y. Yu, C. P. Kirschke, E. R. Gertz, and K. K. C. Lloyd Znt7 (Slc30a7)-deficient Mice Display Reduced Body Zinc Status and Body Fat Accumulation J. Biol. Chem., December 21, 2007; 282(51): 37053 - 37063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Aydemir, R. K. Blanchard, and R. J. Cousins Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations PNAS, February 7, 2006; 103(6): 1699 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Huang, C. P. Kirschke, Y. Zhang, and Y. Y. Yu The ZIP7 Gene (Slc39a7) Encodes a Zinc Transporter Involved in Zinc Homeostasis of the Golgi Apparatus J. Biol. Chem., April 15, 2005; 280(15): 15456 - 15463. [Abstract] [Full Text] [PDF]
|
|
